97 results  1 of 5 

1 Recent Advances in Molecular Basis of Lung Aging and Its Associated Diseases
Min-Jong Kang
Tuberc Respir Dis.2020;83(2):107-115.   Published online 2020 March 10     DOI: http://dx.doi.org/10.4046/trd.2020.0003
2 Risk Factors for Nutritional Status in Patients with Chronic Obstructive Pulmonary Disease
Jun Hee Jang, Hye Sook Min, Jin-Han Park
Korean J Adult Nurs.2019;31(6):585-594.   Published online 2019 December 21     DOI: http://dx.doi.org/10.7475/kjan.2019.31.6.585
3 Comparisons of the Characteristics for Non-hospitalized, Hospitalized, and Rehospitalized Patients due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Ja Yun Choi, So Young Yun
Korean J Adult Nurs.2019;31(4):427-438.   Published online 2019 August 23     DOI: http://dx.doi.org/10.7475/kjan.2019.31.4.427
4 Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation
Hyung Jun Park, Soo Han Kim, Ho-Cheol Kim, Bo Young Lee, Sei Won Lee, Jae Seung Lee, Sang-Do Lee, Joon Beom Seo, Yeon-Mok Oh
Tuberc Respir Dis.2019;82(3):234-241.   Published online 2019 May 31     DOI: http://dx.doi.org/10.4046/trd.2018.0087
5 Correlation between Physical Activity and Lung Function in Dusty Areas: Results from the Chronic Obstructive Pulmonary Disease in Dusty Areas (CODA) Cohort
Yuri Han, Yeonjeong Heo, Yoonki Hong, Sung Ok Kwon, Woo Jin Kim
Tuberc Respir Dis.2019;82(4):311-318.   Published online 2019 May 31     DOI: http://dx.doi.org/10.4046/trd.2019.0006
6 Pharmacotherapy for chronic obstructive pulmonary disease
Yong Suk Jo, Yong Bum Park
J Korean Med Assoc.2019;62(5):277-282.   Published online 2019 May 16     DOI: http://dx.doi.org/10.5124/jkma.2019.62.5.277
7 Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
Tae Hoon Kim, Chin Kook Rhee, Yeon-Mok Oh
Tuberc Respir Dis.2019;82(1):35-41.   Published online 2018 December 19     DOI: http://dx.doi.org/10.4046/trd.2018.0050
8 Risk Factors for Unawareness of Obstructive Airflow Limitation among Adults with Chronic Obstructive Pulmonary Disease
Mirae Jo, Heeyoung Oh
J Korean Acad Community Health Nurs.2018;29(3):290-299.   Published online 2018 September 28     DOI: http://dx.doi.org/10.12799/jkachn.2018.29.3.290
9 Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea
Changhwan Kim, Younhee Kim, Dong-Wook Yang, Chin Kook Rhee, Sung Kyoung Kim, Yong-Il Hwang, Yong Bum Park, Young Mok Lee, Seonglim Jin, Jinkyeong Park, Cho-Rom Hahm, Chang-Han Park, So Yeon Park, Cheol Kweon Jung, Yu-Il Kim, Sang Haak Lee, Hyoung Kyu Yoon, Jin Hwa Lee, Seong Yong Lim, Kwang Ha Yoo
Tuberc Respir Dis.2019;82(1):27-34.   Published online 2018 September 28     DOI: http://dx.doi.org/10.4046/trd.2018.0035
10 Prevalence and socioeconomic burden of chronic obstructive pulmonary disease
Tai Joon An, Hyoung Kyu Yoon
J Korean Med Assoc.2018;61(9):533-538.   Published online 2018 September 18     DOI: http://dx.doi.org/10.5124/jkma.2018.61.9.533
11 The diagnosis of chronic obstructive pulmonary disease according to current guidelines
Hyun Jung Kim, Yeon-Mok Oh
J Korean Med Assoc.2018;61(9):539-544.   Published online 2018 September 18     DOI: http://dx.doi.org/10.5124/jkma.2018.61.9.539
12 Pharmacotherapy for chronic obstructive pulmonary disease
In Ae Kim, Yong Bum Park, Kwang Ha Yoo
J Korean Med Assoc.2018;61(9):545-551.   Published online 2018 September 18     DOI: http://dx.doi.org/10.5124/jkma.2018.61.9.545
13 Treatment and prevention of acute exacerbation of chronic obstructive pulmonary disease
Seong Yong Lim, Hyun Jung Kim, Seung Won Ra, Ji-Hyun Lee, Tae-Hyung Kim
J Korean Med Assoc.2018;61(9):552-556.   Published online 2018 September 18     DOI: http://dx.doi.org/10.5124/jkma.2018.61.9.552
14 Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?
Marc Miravitlles, Seungjae Baek, Vatsal Vithlani, Rahul Lad
Tuberc Respir Dis.2018;81(3):198-215.   Published online 2018 June 19     DOI: http://dx.doi.org/10.4046/trd.2018.0040
15 Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study
Hyonsoo Joo, Deokjae Han, Jae Ha Lee, Chin Kook Rhee
Tuberc Respir Dis.2018;81(4):299-304.   Published online 2018 June 19     DOI: http://dx.doi.org/10.4046/trd.2018.0015
16 Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary
Yong-Bum Park, Chin Kook Rhee, Hyoung Kyu Yoon, Yeon-Mok Oh, Seong Yong Lim, Jin Hwa Lee, Kwang-Ha Yoo, Joong Hyun Ahn,
Tuberc Respir Dis.2018;81(4):261-273.   Published online 2018 June 19     DOI: http://dx.doi.org/10.4046/trd.2018.0029
17 Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Marcos I. Restrepo, Oriol Sibila, Antonio Anzueto
Tuberc Respir Dis.2018;81(3):187-197.   Published online 2018 June 15     DOI: http://dx.doi.org/10.4046/trd.2018.0030
18 Continued Innovation in Respiratory Care: The Importance of Inhaler Devices
Sinthia Zrinka Bosnic-Anticevich
Tuberc Respir Dis.2018;81(2):91-98.   Published online 2018 March 22     DOI: http://dx.doi.org/10.4046/trd.2017.0119
19 The Phosphodiesterase 4 Inhibitor Roflumilast Protects against Cigarette Smoke Extract-Induced Mitophagy-Dependent Cell Death in Epithelial Cells
Sun Young Kyung, Yu Jin Kim, Eun Suk Son, Sung Hwan Jeong, Jeong-Woong Park
Tuberc Respir Dis.2018;81(2):138-147.   Published online 2018 March 13     DOI: http://dx.doi.org/10.4046/trd.2017.0115
20 Comparison of Multiple Chronic Obstructive Pulmonary Disease (COPD) Indices in Chinese COPD Patients
Jinsong Zhang, Anastasia Miller, Yongxia Li, Qinqin Lan, Ning Zhang, Yanling Chai, Bing Hai
Tuberc Respir Dis.2018;81(2):116-122.   Published online 2018 March 7     DOI: http://dx.doi.org/10.4046/trd.2017.0082

 1 of 5